Monoclonal antibodies for prophylaxis and therapy of infectious diseases

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.12, Iss.4, 2007-11, pp. : 525-540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases

Current Pharmaceutical Design, Vol. 14, Iss. 24, 2008-08 ,pp. : 2401-2414

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4498-4507

Bentham Science Publishers

Access to resources Recommend Favorite

Aminoglycoside therapy in infectious diseases

By Poulikakos Panagiotis Falagas Matthew E

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1585-1597

Informa Healthcare

Access to resources Recommend Favorite

Bispecific antibodies for the treatment of tumours and infectious diseases

By Drakeman D.L. Fanger M.W. Wallace P.K.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1169-1178

Informa Healthcare

Access to resources Recommend Favorite

Infectious Complications Associated With Immunomodulating Monoclonal Antibodies Used in the Treatment of Hematologic Malignancy

By Koo Sophia Baden Lindsey R.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 2, 2008-02 ,pp. : 202-213

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite